Nisoxetine
Nisoxetine is a norepinephrine (noradrenaline) reuptake inhibitor that is used in scientific research. It was developed by Eli Lilly and was studied as an antidepressant, but was never marketed.
History[edit | edit source]
Nisoxetine was one of the first reuptake inhibitors to be developed. It was created by the pharmaceutical company Eli Lilly in the 1970s. Despite showing promise as an antidepressant, it was never marketed for this use.
Pharmacology[edit | edit source]
Nisoxetine acts primarily as a norepinephrine (noradrenaline) reuptake inhibitor. This means it increases the amount of norepinephrine in the brain by preventing it from being reabsorbed into nerve cells. This can have various effects on mood and behavior.
Research[edit | edit source]
Nisoxetine has been used in scientific research to study the role of norepinephrine in the brain. It has been used in studies investigating conditions such as depression, anxiety disorders, and attention deficit hyperactivity disorder (ADHD).
See also[edit | edit source]
References[edit | edit source]
Nisoxetine Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD